Who Should Not Take Ashwagandha? Liver, Thyroid and Medicines
In this article
- Who should not take ashwagandha?
- What should you never mix with ashwagandha?
- Is ashwagandha bad for your liver?
- Is ashwagandha bad for kidneys?
- Is ashwagandha hard on your heart?
- Does ashwagandha affect the thyroid?
- What are the side effects of ashwagandha?
- What do UK and European regulators say?
- What we don't know
- Frequently asked questions
Ashwagandha should not be taken by anyone pregnant or breastfeeding, by under-18s, by people with liver disease or heavy alcohol use, by anyone with a thyroid condition or on thyroid medicine, by people with autoimmune disease or on immunosuppressants, or alongside sedatives, and it is stopped before surgery. People on diabetes, blood-pressure, antidepressant or anticoagulant medicines ask a pharmacist first. The reasons are numbers, not alarm: about 25 published cases of liver injury, typically after weeks of use; thyroxine up across 23 pooled trials with TSH unchanged; and three case reports of thyrotoxicosis that resolved on stopping, set against 23 safety trials in 2,317 healthy adults whose liver, kidney and hormone markers stayed inside normal ranges.1, 2, 3, 4 Neither "100% safe" nor "dangerous" fits. Part of the Wellgard ashwagandha guide and the Wellgard sleep guide.
Sources checked on 1 November 2026.
Who should not take ashwagandha?
- Pregnant or breastfeeding women: the French food-safety agency advises against it, and the NHS says not to take herbal medicines when pregnant or breastfeeding.18, 15
- Under-18s: the NHS does not recommend herbal medicines for children because not enough is known about their safety.15
- Liver disease or heavy drinking: all three published liver deaths had existing cirrhosis, and alcohol may add to the risk.1, 5
- Any thyroid condition, or levothyroxine or liothyronine: thyroxine rises; see below.
- Autoimmune disease, or methotrexate, biologics, ciclosporin or tacrolimus: immune-stimulating activity in laboratory work, and one transplant patient's kidney was rejected after two weeks of it.17
- Sedatives and anti-seizure medicines: drowsiness occurs in trials, and the French food-safety agency advises people on sedative medicines not to take it.4, 18
- Surgery: the US National Institutes of Health's complementary-health institute does not recommend it before surgery; tell the pre-operative team, as the NHS advises telling any doctor treating you about a herbal medicine.15
- Hormone-sensitive prostate cancer: testosterone rises in men, and the US complementary-health institute advises avoiding it.2
What should you never mix with ashwagandha?
"Ask the pharmacist" never means "stop your medicine": that is the prescriber's decision.
| Medicine (UK generic names) | What the evidence shows | What to ask the pharmacist |
|---|---|---|
| Levothyroxine, liothyronine | Thyroxine up 0.61 µg/dL across 23 trials, TSH unchanged; three thyrotoxicosis reports2, 3, 10 | Whether to take it at all; if so, when to retest |
| Benzodiazepines (diazepam), z-drugs (zopiclone), sedating antihistamines (promethazine), anti-seizure medicines (gabapentin, pregabalin) | Drowsiness in trials; a GABA-related action proposed; the French food-safety agency advises against it with sedatives4, 7, 18 | Driving and work while drowsy |
| Methotrexate, biologics (adalimumab, etanercept), ciclosporin, tacrolimus | Immune-stimulating activity in animal studies; one kidney-transplant rejection on tacrolimus; no trial in people on them17 | Ask the rheumatology or transplant team |
| SSRIs and other antidepressants (sertraline, citalopram, escitalopram, mirtazapine) | Serotonin rose in pooled trials; one withdrawal case; the NHS lists antidepressants among medicines that may not mix with herbal medicines2, 7, 15 | Tell the prescriber first; report any flatness |
| Diabetes medicines (metformin, gliclazide, insulin) | Fasting glucose about 0.2 mmol/L lower across 11 trials, HbA1c inconclusive, very low certainty8 | Whether to check readings more often |
| Blood-pressure medicines (amlodipine, ramipril, losartan) | Heart markers stayed within normal ranges in the safety trials; no trial of the combination; on the NHS list of medicines that may not mix with herbal medicines4, 15 | Whether to check blood pressure at home |
| Anticoagulants and antiplatelets (warfarin, apixaban, clopidogrel) | No human report of bleeding or an interaction found in a PubMed search on 1 November 2026; warfarin is on the NHS list of medicines that may not mix with herbal medicines15 | Tell the anticoagulant clinic |
Dispensing checks do not cover supplements, so bring the pack; ashwagandha vs lion's mane carries both sets of cautions.
Is ashwagandha bad for your liver?
Rarely, and recognisably. A review to December 2025 found 25 patients in 13 published reports: injury after weeks of use, usually cholestatic or mixed, with jaundice and itching; most recovered over weeks to months; one transplant; three deaths, all with existing cirrhosis.1 In the first case series, five patients in Iceland and the US fell ill 2 to 12 weeks after starting; itching and jaundice lasted 5 to 20 weeks, and liver tests were normal within 1 to 5 months in the four followed up.6 Eight Indian cases confirmed the pattern, the three deaths among five patients with existing chronic liver disease.5 Against this, the 23 trials in 2,317 healthy adults kept liver tests normal to 180 days, as did an 80-person trial at 600 mg a day for 8 weeks; both enrolled healthy adults, so a rare reaction cannot be ruled out.4, 9 Dark urine, pale stools, itching, nausea or pain under the right ribs mean stop and see a GP; for yellow skin or eyes the NHS says to ask for an urgent GP appointment or call NHS 111.14
Is ashwagandha bad for kidneys?
Kidney markers stayed within normal ranges across the 23 safety trials in 2,317 healthy adults for up to 180 days, but none enrolled anyone with chronic kidney disease, on dialysis or with a transplant, so they cannot speak for those groups.4 One published case points the other way: a 69-year-old man with a kidney transplant developed acute rejection about two weeks after starting ashwagandha and lost the kidney; his doctors found no other trigger and advise warning transplant recipients.17 The NHS says not to take herbal medicines if you have kidney problems.15 So with kidney disease, dialysis or a transplant, ask the renal team first. The full kidney record is on the side effects of ashwagandha.
Is ashwagandha hard on your heart?
Cardiovascular markers stayed normal in the safety trials of healthy adults, and the French food-safety agency advises people with heart disorders not to take it.4, 18 One published case explains palpitations: a 73-year-old woman's fast heart rhythm came from thyrotoxicosis and settled when she stopped the supplement.3 New palpitations are a GP visit, with a thyroid test.
Does ashwagandha affect the thyroid?
In one direction: up. Pooled across 23 trials, thyroxine (T4) rose by 0.61 µg/dL while TSH and T3 did not change; in 50 people with subclinical hypothyroidism, 600 mg a day for 8 weeks lowered TSH and raised T4 against placebo; and three thyrotoxicosis case reports resolved on stopping.2, 3, 10 So anyone on levothyroxine or liothyronine, or with Hashimoto's, Graves' disease, a thyroid gland removed or treated with radioiodine, asks their GP first (see can I take ashwagandha with levothyroxine), and ashwagandha is never a replacement for thyroid medicine.
What are the side effects of ashwagandha?
In the trials: mild stomach upset, headache and drowsiness, at rates similar to placebo.4 One published case describes insomnia, a racing heart and anxiety after stopping 600 mg a day abruptly, the authors allowing that the underlying anxiety may have returned.7 Anyone who feels flat or unmotivated on it stops, seeing a GP if it persists; anyone on antidepressants involves their prescriber (can you take sleep supplements with antidepressants); a suspected reaction can be reported to your local authority's food safety team, which works with the Food Standards Agency.11 What ashwagandha does for the brain covers flatness; is ashwagandha safe to take daily covers how to stop.
What do UK and European regulators say?
Only one country prohibits it. Denmark's 2020 risk assessment could set no intake free of risk, and Denmark prohibits ashwagandha in food; the Netherlands advised against its supplements and teas in March 2024; France (April 2024) and Germany (September 2024) said pregnant and breastfeeding women, under-18s and people with liver disease should not take it, France adding thyroid, androgen and heart disorders and sedatives; neither banned it.18 UK: the Food Standards Agency ran a call for evidence from 8 July to 2 September 2024, published its summary of the 19 responses on 25 June 2026 and passed them to the Committee on Toxicity. Ashwagandha has open safety questions that the UK Committee on Toxicity is assessing; its draft statement is not yet published.12, 13 So: legal in UK supplements, and not available on the NHS, which does not use herbal medicines; the UK assessment is unfinished (position at 1 November 2026).15
What we don't know
How often ashwagandha injures the liver, and who is at risk: 25 published cases cannot give a rate, and the safety trials enrolled healthy adults.1, 4 Whether it interacts with particular medicines in people: the cautions above rest on hormone and glucose changes in trials, laboratory work and case reports, not on trials of the combinations. Whether it is safe in pregnancy: the one trial in pregnant women was small, open-label and did not report birth outcomes.16 And what the UK will conclude: the Committee on Toxicity's statement is not yet published.13
Frequently asked questions
Can I take ashwagandha with magnesium, vitamin D or my other vitamins?
No interaction with magnesium, vitamin D or a multivitamin is reported in trials or case literature; the caution is additive drowsiness if the other product is a sleep blend.
Why don't doctors recommend ashwagandha?
Because it is a food supplement with no authorised health claim, no licensed use and small, short trials, and because of the interactions and liver cases above. Herbal medicines are not available on the NHS, so a GP cannot prescribe it or vouch for a product.15
Is ashwagandha safe for men, and does it increase testosterone?
For men without the conditions above, the trials raise no specific concern. Testosterone was about 57 ng/dL higher across 23 pooled trials; the trial that measured fatigue, vigour and sexual well-being alongside it found no difference from placebo.2
Is it safe to take ashwagandha while pregnant?
No: ashwagandha must not be taken in pregnancy or while breastfeeding, when the NHS says not to take herbal medicines.15 One open-label 12-week trial of 70 women in mid-pregnancy, on an extract its maker supplied, recorded no adverse events; it was small, unblinded and did not report birth outcomes, so the advice stands.16
Can ashwagandha cause kidney stones?
No published report links ashwagandha to kidney stones: a PubMed search, repeated on 1 November 2026, found no case report and no trial that measured stone risk, so there is no human evidence either way. Anyone who has had kidney stones falls under the NHS advice not to take herbal medicines with kidney problems, so the GP or renal team decides.15
Sources
- McIntyre D, et al. Ashwagandha (Withania somnifera)-associated liver injury: a scoping review of clinical characteristics and safety considerations. Cureus, 2026. Scoping review, 13 case publications, 25 patients; no funding received. PubMed 42367407.
- Fornalik M, et al. Hormonal modulation with Withania somnifera: systematic review and meta-analysis of randomized-controlled trials. Planta Medica, 2026. Systematic review and meta-analysis, 23 randomised trials, 1,706 adults; no conflicts declared, funder not stated. PubMed 41740946; Lopresti AL, et al. Hormonal and vitality effects of ashwagandha in aging, overweight males: a randomized, double-blind, placebo-controlled, crossover study. American Journal of Men's Health, 2019. Randomised placebo-controlled crossover trial, 57 men aged 40 to 70, 8 weeks per phase; funded by the extract's maker. PubMed 30854916.
- Kamal HI, et al. Ashwagandha as a unique cause of thyrotoxicosis presenting with supraventricular tachycardia. Cureus, 2022. Case report, 1 woman aged 73; no competing interests declared. PubMed 35475098.
- Coope OC, et al. Back to the roots: safety and tolerability of standardised ashwagandha (Withania somnifera) root extract in healthy adults, a systematic review of biomarkers and adverse events. Pharmaceuticals, 2026. Systematic review, 23 randomised trials, 2,317 healthy adults; no external funding, two authors employed by UK supplement companies. PubMed 42198398.
- Philips CA, et al. Ashwagandha-induced liver injury: a case series from India and literature review. Hepatology Communications, 2023. Case series, 8 patients from Indian centres; no conflicts declared. PubMed 37756041.
- Björnsson HK, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 2020. Case series, 5 patients; US National Institutes of Health funding. PubMed 31991029.
- Holzman A, et al. Unmasking potential withdrawal effects of ashwagandha: a case report and review. Cureus, 2025. Case report, 1 man; no funding received. PubMed 40476122.
- Farrin N, et al. The effects of ashwagandha (Withania somnifera) supplementation on fasting blood glucose and HbA1c: a systematic review and dose-response meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice, 2026. Systematic review and meta-analysis, 11 randomised trials, 667 people, very low certainty; no competing interests declared. PubMed 42641800.
- Verma N, et al. Safety of ashwagandha root extract: a randomized, placebo-controlled study in healthy volunteers. Complementary Therapies in Medicine, 2021. Randomised placebo-controlled trial, 80 healthy adults, 8 weeks; funder not stated in the abstract. PubMed 33338583.
- Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. Journal of Alternative and Complementary Medicine, 2018. Randomised placebo-controlled pilot trial, 50 adults with subclinical hypothyroidism, 8 weeks; funder not stated in the abstract. PubMed 28829155; van der Hooft CS, et al. Thyrotoxicosis following the use of ashwagandha. Nederlands Tijdschrift voor Geneeskunde, 2005. Case report, 1 woman. PubMed 16355578; Hayashi M, et al. Painless thyroiditis by Withania somnifera (ashwagandha). Cureus, 2024. Case report, 1 man; no competing interests declared. PubMed 38559552.
- Food Standards Agency. How to report a food safety or hygiene issue for members of the public. Updated 5 August 2026. gov.uk.
- Food Standards Agency. Summary of responses to call for evidence on ashwagandha, 25 June 2026; 19 responses. gov.uk.
- Committee on Toxicity. 8th September 2026 meeting: third draft statement on ashwagandha discussed; paper TOX/2026/30 not yet available on 1 November 2026. gov.uk.
- NHS. Jaundice. Page last reviewed 22 January 2024. nhs.uk.
- NHS. Herbal medicines and complementary therapies. Page last reviewed 1 May 2026. nhs.uk.
- Ajgaonkar A, et al. Frontiers in Global Women's Health, 2026. Open-label randomised trial, 70 pregnant women, 12 weeks; extract supplied by its maker, no funding received. PubMed 41767760.
- Sriperumbuduri S, et al. Ashwagandha and kidney transplant rejection. Kidney International Reports, 2020. Case report, one man; funder not stated. PubMed 33305135.
- ANSES (French food-safety agency). Opinion 2021-SA-0077 on the risks of Withania somnifera preparations in food supplements, 19 April 2024, including the Danish (2020) and Dutch (2024) assessments. Expert committee opinion. anses.fr.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.